IVIVR Assessing PK Parameters Used to Establish Bioequivalence
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether defined and limited changes in in vitro
dissolution impact the in vivo pharmacokinetics (PK) and relative bioavailability of
allopurinol and the active metabolite oxypurinol.